Case File №
#VI-2026-0550
ZZQ Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 11 | 6.9 | 0.0 | 9.5 | 24 Jul 2025 |
| Tirzepatide | E Bad | 11 | 5.8 | 1.3 | 7.8 | 3 Jul 2025 |
| AA Water | X N/A | 1 | 6.9 | 6.9 | 6.9 | 27 Feb 2025 |
| AHK-CU | E Bad | 2 | 5.8 | 5.2 | 6.5 | 25 May 2026 |
| AICAR Oral | X N/A | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 |
| AICAR | X N/A | 1 | 6.4 | 6.4 | 6.4 | 13 Jun 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 7.9 | 7.9 | 7.9 | 7 May 2025 |
| Blend 500 (Tren E/Mast E) | E Bad | 2 | 6.3 | 4.9 | 7.8 | 19 Jan 2026 |
| BMK glycidic acid (free acid) CAS 25547-51-7 | X N/A | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 |
| Botulinum toxin | E Bad | 2 | 4.0 | 2.6 | 4.7 | 17 May 2026 |
| BPC157 10mg + TB500 10mg Blend | E Bad | 2 | 5.9 | 5.3 | 6.6 | 25 May 2026 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 9.1 | 9.1 | 9.1 | 2 Jul 2025 |
| Cerebrolysin | E Bad | 2 | 4.7 | 4.6 | 4.7 | 20 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | E Bad | 2 | 5.9 | 3.8 | 8.0 | 23 May 2026 |
| Dihexa | X N/A | 1 | 7.8 | 7.8 | 7.8 | 13 Feb 2025 |
| DNP | X N/A | 1 | 5.1 | 5.1 | 5.1 | 8 Jul 2025 |
| Dutasteride | X N/A | 1 | 7.1 | 7.1 | 7.1 | 2 Apr 2025 |
| Fluoxymesterone (Halotestin) Raw | E Bad | 2 | 5.3 | 5.1 | 5.6 | 24 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 |
| GW-501516 (Cardarine) Raw | X N/A | 1 | 5.1 | 5.1 | 5.1 | 24 Apr 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 |
| Liraglutide | E Bad | 2 | 7.1 | 5.3 | 8.9 | 19 Jan 2026 |
| Livagen | X N/A | 1 | 4.0 | 4.0 | 4.0 | 13 Feb 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 6.3 | 6.3 | 6.3 | 13 Jun 2025 |
| Minoxidil Oral | X N/A | 1 | 4.7 | 4.7 | 4.7 | 20 Jun 2025 |
| Nandrolone Phenylpropionate (NPP) Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 3 Jul 2025 |
| NandroMix 300 | X N/A | 1 | 5.0 | 5.0 | 5.0 | 8 Jul 2025 |
| Ovagen | E Bad | 2 | 6.0 | 6.0 | 6.1 | 26 Jan 2026 |
| PEG MGF | E Bad | 2 | 6.5 | 6.4 | 6.5 | 26 Jan 2026 |
| Primobolan Oral (Methenolone Acetate) | E Bad | 2 | 6.1 | 6.0 | 6.2 | 24 May 2026 |
| Proviron (Mesterolone) | E Bad | 2 | 5.8 | 4.2 | 7.3 | 21 May 2026 |
| PTD-DBM | E Bad | 2 | 7.0 | 6.6 | 7.4 | 19 Jan 2026 |
| Semax | X N/A | 1 | 5.1 | 5.1 | 5.1 | 7 May 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 3.3 | 3.3 | 28 Mar 2025 |
| T3 (Liothyronine) | E Bad | 2 | 6.8 | 6.2 | 7.5 | 17 May 2026 |
| T4 (Levothyroxine) | X N/A | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 |
| Test Suspension | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| Testosterone Cypionate Raw | E Bad | 2 | 8.6 | 7.1 | 10.0 | 24 May 2026 |
| Tren Base | X N/A | 1 | 4.6 | 4.6 | 4.6 | 27 Feb 2025 |
| Vilon | E Bad | 2 | 6.7 | 5.5 | 7.8 | 20 May 2026 |
| Vitamin B12 10mg/ml | X N/A | 1 | 7.7 | 7.7 | 7.7 | 7 May 2025 |
Exhibit II
Evidence Log
62 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | PTD-DBM | 10.0 A | 15mg | 16.9mg | +12.9% | 99.52% | 0jp93p | Lab F | Community |
| 24 May 2026 | T3 (Liothyronine) | 5.7 B | 50mg | 43.3mg | -13.3% | 96.77% | vqat9r | Lab G | Public |
| 24 May 2026 | Tren Base | 4.5 C | 100mg/ml | 105.5mg/ml | +5.5% | 98.12% | d571fe | Lab F | Public |
| 24 May 2026 | Tirzepatide | 5.8 C | 20mg | 20.5mg | +2.5% | 98.75% | (no batch ID) | Lab E | Public |
| 24 May 2026 | Tirzepatide | 5.3 C | 30mg | 29.6mg | -1.3% | 98.25% | (no batch ID) | Lab E | Public |
| 24 May 2026 | Tirzepatide | 6.0 B | 10mg | 10.2mg | +2.0% | 98.98% | (no batch ID) | Lab E | Public |
| 24 May 2026 | Tirzepatide | 6.4 B | 30mg | 30.2mg | +0.7% | 99.18% | (no batch ID) | Lab E | Public |
| 24 May 2026 | DNP | 5.0 B | 50mg | 50.7mg | +1.4% | 99.02% | 95m8ds | Lab C | Community |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 4.8 C | 50mg | 53.1mg | +6.2% | 97.62% | r5o9mp | Lab E | Public |
| 24 May 2026 | Fluoxymesterone (Halotestin) Raw | 4.2 C | 100g | 92.6g | -7.4% | 96.12% | 6try57 | Lab F | Community |
| 24 May 2026 | Proviron (Mesterolone) | 5.4 B | 100mg | 117.8mg | +17.8% | 96.29% | rxnv9o | Lab F | Public |
| 23 May 2026 | GW-501516 (Cardarine) Raw | 5.8 B | 1g | 1.0g | -1.9% | 99.71% | eqwak9 | Lab F | Community |
| 23 May 2026 | Ovagen | 6.0 A | 50mg | 46.1mg | -7.8% | 97.47% | 69yhza | Lab D | Public |
| 23 May 2026 | Proviron (Mesterolone) | 4.6 C | 25mg | 23.8mg | -4.7% | 98.79% | 0i63xy | Lab D | Public |
| 23 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.4 C | 2mg | 2.1mg | +6.1% | 97.89% | xdjhj9 | Lab D | Public |
| 23 May 2026 | Fluoxymesterone (Halotestin) Raw | 5.9 B | 500g | 429.0g | -14.2% | 98.48% | 9ru53w | Lab F | Public |
| 23 May 2026 | Vilon | 7.3 A | 50mg | 46.1mg | -7.9% | 95.78% | vevono | Lab D | Public |
| 21 May 2026 | Tirzepatide | 1.3 E | 60mg | 18.3mg | -69.5% | 93.57% | (no batch ID) | Lab E | Public |
| 21 May 2026 | Tirzepatide | 5.0 C | 30mg | 51.2mg | +70.7% | 99.32% | ZZQTR30122025 | Lab E | Public |
| 21 May 2026 | Retatrutide | 7.6 A | 20mg | 23mg | +15.0% | 99.90% | ZZQRT20122025 | Lab E | Public |
| 21 May 2026 | Dutasteride | 7.3 A | 50mg | 60.6mg | +21.2% | 95.31% | a603h9 | Lab B | Public |
| 20 May 2026 | Ovagen | 5.8 B | 10mg | 11.2mg | +12.0% | 99.55% | ep7cbs | Lab A | Public |
| 19 May 2026 | AICAR Oral | 5.5 B | 10mg | 11.8mg | +18.4% | 96.83% | agz9jt | Lab G | Public |
| 19 May 2026 | Liraglutide | 9.5 A | 30mg | 27.3mg | -8.9% | 99.05% | pjkk68 | Lab F | Public |
| 19 May 2026 | Testosterone Cypionate Raw | 8.4 A | 500g | 474.0g | -5.2% | 96.53% | hjaw4z | Lab C | Community |
| 17 May 2026 | Dihexa | 9.6 A | 10mg | 9.8mg | -2.2% | 96.05% | fyo1o2 | Lab E | Public |
| 29 Jan 2026 | Blend 500 (Tren E/Mast E) | 7.0 A | 200mg/ml | 219.7mg/ml | +9.9% | 95.68% | v191d7 | Lab F | Community |
| 29 Jan 2026 | IGF-1 LR3 | 4.2 C | 15mg | 18.5mg | +23.6% | 95.28% | 8qdy1c | Lab E | Public |
| 29 Jan 2026 | Livagen | 4.0 C | 50mg | 47.3mg | -5.4% | 99.66% | kqo4y2 | Lab B | Public |
| 29 Jan 2026 | Minoxidil Oral | 5.8 B | 10mg | 9.3mg | -7.2% | 97.35% | 8m973d | Lab D | Community |
| 29 Jan 2026 | PTD-DBM | 7.1 A | 20mg | 20.4mg | +2.2% | 98.77% | zhb8g8 | Lab A | Public |
| 29 Jan 2026 | Vilon | 5.4 B | 20mg | 23.0mg | +14.8% | 98.23% | tm8wd9 | Lab D | Public |
| 26 Jan 2026 | AICAR | 8.2 A | 50mg | 55.4mg | +10.9% | 96.99% | 36hn99 | Lab F | Public |
| 26 Jan 2026 | BMK glycidic acid (free acid) CAS 25547-51-7 | 7.4 A | 1g | 0.9g | -9.0% | 98.61% | s1rukt | Lab D | Public |
| 26 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 10.0 A | 2mg | 2.5mg | +23.7% | 98.23% | 3z5chq | Lab B | Community |
| 26 Jan 2026 | Cerebrolysin | 4.0 C | 20mg | 22.5mg | +12.5% | 96.01% | l65gkw | Lab B | Public |
| 26 Jan 2026 | Semax | 5.9 B | 30mg | 35.9mg | +19.8% | 96.81% | pol4my | Lab E | Community |
| 19 Jan 2026 | Botulinum toxin | 4.0 C | 50mg | 50.6mg | +1.2% | 97.49% | 7fje3x | Lab C | Public |
| 19 Jan 2026 | Vitamin B12 10mg/ml | 8.7 A | 300mg/ml | 322.0mg/ml | +7.3% | 96.81% | sfnvuq | Lab G | Community |
| 7 Jan 2026 | T3 (Liothyronine) | 5.6 B | 100mg | 89.6mg | -10.4% | 95.75% | xv5ctm | Lab F | Public |
| 7 Jan 2026 | Test Suspension | 6.4 A | 300mg/ml | 285.2mg/ml | -4.9% | 99.26% | q4195a | Lab F | Public |
| 5 Dec 2025 | AHK-CU | 6.0 A | 30mg | 32.4mg | +7.9% | 96.88% | 4bfolg | Lab F | Public |
| 5 Dec 2025 | Blend 300 (TRA/Mast P/Test P) | 6.5 A | 100mg/ml | 124.6mg/ml | +24.6% | 98.04% | c42h8w | Lab E | Community |
| 5 Dec 2025 | Cerebrolysin | 4.9 C | 15mg | 18.0mg | +19.8% | 96.47% | gb9rqq | Lab F | Public |
| 5 Dec 2025 | PEG MGF | 7.7 A | 2mg | 1.9mg | -3.1% | 99.88% | 5k9bpq | Lab G | Public |
| 23 Nov 2025 | AA Water | 8.5 A | 15mg | 16.5mg | +10.2% | 99.94% | x20tow | Lab A | Community |
| 23 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.0 A | 15mg | 13.7mg | -8.4% | 98.25% | rrxu33 | Lab F | Public |
| 23 Nov 2025 | SNAP-8 | 5.2 B | 20mg | 24.7mg | +23.7% | 97.91% | cz671t | Lab B | Public |
| 23 Nov 2025 | T4 (Levothyroxine) | 8.1 A | 100mg | 112.1mg | +12.1% | 95.30% | l386ki | Lab D | Public |
| 17 Nov 2025 | Blend 500 (Tren E/Mast E) | 6.6 A | 100mg/ml | 87.4mg/ml | -12.6% | 95.19% | vl4ks5 | Lab F | Public |
| 17 Nov 2025 | Masteron P (Drostanolone P) | 6.4 A | 200mg/ml | 204.3mg/ml | +2.2% | 97.03% | t5agyu | Lab B | Public |
| 17 Nov 2025 | Testosterone Cypionate Raw | 8.5 A | 10g | 12.4g | +23.9% | 96.32% | 5lgh8w | Lab C | Public |
| 14 Nov 2025 | Liraglutide | 8.9 A | 5mg | 4.3mg | -14.8% | 96.16% | cf5hrd | Lab A | Community |
| 5 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 6.7 A | 2mg | 1.7mg | -14.9% | 96.69% | l468ka | Lab C | Public |
| 5 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.4 A | 50mg | 45.8mg | -8.5% | 96.11% | b4kl5i | Lab E | Public |
| 5 Nov 2025 | NandroMix 300 | 5.7 B | 200mg/ml | 194.6mg/ml | -2.7% | 97.12% | 922fpy | Lab F | Community |
| 4 Nov 2025 | AHK-CU | 4.3 C | 30mg | 26.5mg | -11.5% | 96.61% | 32hm3e | Lab B | Public |
| 4 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 6.7 A | 2mg | 2.1mg | +7.5% | 96.96% | 053fzo | Lab A | Community |
| 4 Nov 2025 | Nandrolone Phenylpropionate (NPP) Raw | 5.6 B | 100g | 107.3g | +7.3% | 95.39% | 2l51d9 | Lab B | Community |
| 4 Nov 2025 | PEG MGF | 7.6 A | 10mg | 11.7mg | +16.9% | 99.18% | t7ucuw | Lab E | Public |
| 17 Oct 2025 | Botulinum toxin | 4.0 C | 15mg | 14.0mg | -6.4% | 97.06% | e5j655 | Lab C | Community |
| 17 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 6.7 A | 10mg | 9.3mg | -7.2% | 98.48% | 9izx5z | Lab E | Public |
— END OF EVIDENCE LOG —